Molecular Biology of Erythropoiesis pp 177-183 | Cite as
Butyric Acid Modulates Developmental Globin Gene Switching in Man and Sheep
- 8 Citations
- 66 Downloads
Abstract
The developmental switch from production of fetal (Υ) to adult (ß) globin occurs on a normally set biologic clock which proceeds even if the adult (ß) globin genes are defective. Preventing or reversing the globin gene switch would be beneficial for subjects with abnormal ß globin genes. We have now identified a class of agents which, when present in elevated plasma concentrations during gestation, appears to inhibit the Υ → ß globin gene switch in developing humans. Further investigation has shown that butyric acid and related compounds can increase Υ globin and decrease ß globin expression in erythroid cells cultured from subjects with diseases of abnormal ß globin. Butyrate compounds were therefore infused in an in vivo fetal animal model, and the globin switch was inhibited in most and reversed in some fetal lambs. These data suggest that inhibiting expression of abnormal ß globin genes may be possible in future generations. Histone modification may be a mechanism of action involved.
The developmental switch from production of γ globin to β globin results in significant morbidity when the β globin genes are defective. The globin switch has therefore been extensively studied, appearing to be set on a biologic clock and proceeding despite the site of blood production and solely on the basis of gestational age1. We previously found that this developmental gene switch is delayed in human fetuses developing in the presence of maternal diabetes2. A number of metabolites present in abnormal concentrations in these infants were therefore tested for effects on globin expression. One metabolite, a amino-n-butyric acid (ABA), was found to enhance γ globin and inhibit β globin expression in cultured neonatal erythroid cells3. Further investigation now shows that ABA, sodium butyrate and similar compounds can enhance γ,globin
Keywords
Butyric Acid Histone Acetylation Sodium Butyrate Globin Gene Erythroid CellPreview
Unable to display preview. Download preview PDF.
References
- 1.. Wood, W.G., C. Bunch, S. Kelly, Y. Gunn, G. Breckon. 1985. Control of hemoglobin switching by a developmental clock? Nature 313: 320.PubMedCrossRefGoogle Scholar
- 2.. Perrine, S.P., M.F. Greene, D.V. Faller. 1985. Delayed in the fetal globin switch in infants or diabetic mothers. N. Eng. J. Med. 312: 334.CrossRefGoogle Scholar
- 3.. Perrine, S.P., B.A. Miller, M.F. Greene, R.A. Cohen, N. Cook, C. Shackleton, D.V. Faller. 1987. Butyric acid analogues augment y globin gene expression in neonatal erythroid progenitors. Biochem. Biophys. Res. Commun. 148: 694.Google Scholar
- 4.. Perrine, S.P., B.A. Miller, D.V. Faller, R.A. Cohen, E.P. Vichinsky, D. Hurst, B.H. Lubin, Th. Papayannopoulou. 1989. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with HbSS and ß thalassemia. Blood 74: 454.PubMedGoogle Scholar
- Perrine, S.P., B.A. Miller, D.V. Faller, R.A. Cohen, E.P. Vichinsky, D. Hurst, B.H. Lubin, and Th. Papayannopoulou. 1989. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with HbSS and S thalassemia. Blood 74: 454.Google Scholar
- 5.. Swerdlow, P.S., A. Varsavsky. 1983. Affinity of HMG17 for a mononucleosome is not influenced by the presence of ubiquitin-H2A semihistone but strongly depends on DNA fragment size. Nucleic Acids Res. 11: 387.PubMedCrossRefGoogle Scholar
- 6.. Perrine, S.P., A. Rudolph, D.V. Faller, C. Roman, R.A. Cohen, S-J. Chen, Y.W. Kan. 1988. Butyrate infusion in the ovine fetus delay the biologic clock for globin gene switching. Proc. Natl. Acad. Sci. USA 85: 8540.PubMedCrossRefGoogle Scholar
- 7.. Wood, W.G., M.E. Pembrey, G. Serjeant, R.P. Perrine, D.J. Weatherall. 1980. Haemoglobin F synthesis in sickle cell anaemia: A comparison of Saudi Arab cases with those of African origin. Br. J. Haematol. 45: 431.PubMedCrossRefGoogle Scholar
- 8.. Reed, L.J., T.B. Bradley Jr., H.M. Ranney. 1965. The effect of amelioration of anemia by the synthesis of fetal hemoglobin in sickle cell anemia. Blood 25: 37.PubMedGoogle Scholar
- 9.. Nagel, R.L., R.M. Bookchin, J. Johnson, D. Labie, H. Wajcman, W.A. Isaac-Sodeye, G.R. Honig, G. Schiliro, J.H. Crookston, K. Matsutomo. 1979. Structural bases of the inhibitory effects of hemoglobin F and A2 on the polymerization of hemoglobin S. Proc. Natl. Acad. Sci. USA 75: 670.CrossRefGoogle Scholar
- 10.. Dover, G.J., S.H. Boyer, S. Charache, K. Heintzelman. 1978. Individual variation in the production and survival of F cells in sickle cell disease. N. Engl. J. Med. 299: 1428.PubMedCrossRefGoogle Scholar
- 11.. Burns, L.J., J. Glauber, G.D. Ginder. 1984. Butyrate induces selective gene transcription in injected Xeonopus oocytes: En¬hancement by sodium butyrate. Embo J. 3: 2787.Google Scholar
- . Constantoulakis, P., Th. Papayannopoulou, G. Stamatoyannopoulos. 1988. a-Amino-n-butyric acid stimulates fetal hemoglobin in the adult. Blood 22: 1961.Google Scholar
- 13.. Riggs, M.G., R.G. Wittaker, J.R. Neuman, V.W. Ingram. 1977. N-Butyrate causes histone modification in HeLa and Friend erythro-leukemia cells. Nature 268: 462.PubMedCrossRefGoogle Scholar
- 14.. Kruh, J. 1982. Effects of sodium butyrate, a new pharmacologic agent on cells in culture. Molec. Cell Biochem. 42: 65.Google Scholar
- 15.. Darzynkiewicz, Z., F. Tráganos, S-B. Xue, M.R. Melamed. 1981. Effect of n-butyrate on cell cycle progression and in situ chromatin structure of L1210 cells. Exp. Cell. Res. 136: 279.Google Scholar
- 16.. Prasad, K.N. 1980. Butyric acid, a small fatty acid with diverse biological functions. Life Sciences 27: 1351.PubMedCrossRefGoogle Scholar